Making milestones against non-small cell lung cancer

Anne Li                                                                                     January 26th, 2018


Hard to detect in its early stages and hard to treat as it advances, lung cancer is the leading cause of cancer mortality around the world, with an estimated 1.6 million deaths each year. New treatments, however, are bettering the odds for people with non-small cell lung cancer (NSCLC), which makes up about 85% of lung cancer cases.  Traditionally, NSCLC has been treated by surgery followed by chemotherapy or radiation or both. "Options for treatments have improved in recent years with the advent of two classes of drugs, molecularly targeted therapies and more recently immunotherapies," said Herbst, co-lead author on a paper reviewing advances in NSCLC treatment published in the journal Nature.
See original article at: https://www.sciencedaily.com/releases/2018/01/180124131730.htm

Post a comment